Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Autoimmune-therapies"

2 News Found

Shilpa Medicare signs long-term CDMO manufacturing deal with NXI Therapeutics
News | May 13, 2026

Shilpa Medicare signs long-term CDMO manufacturing deal with NXI Therapeutics

The partnership covers the entire product lifecycle from early-stage development through commercialization


InnoCare Pharma launches global Phase II trial of TYK2 inhibitor for prurigo nodularis in China
Clinical Trials | November 30, 2025

InnoCare Pharma launches global Phase II trial of TYK2 inhibitor for prurigo nodularis in China

Soficitinib is a potent and selective TYK2 inhibitor under development for multiple T-cell mediated autoimmune disorders